Clinical Trial: A Study of Participants With Chronic Kidney Disease Previously Treated With REACT
Study Status: Completed
Recruit Status: RECRUITING
Condition: Diabetic Kidney Disease
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Open-label, Supplemental Dosing Study of Participants With Chronic Kidney Disease Previously Treated With REACT (REGEN-015)
Brief Summary:
The purpose of this study is to evaluate the safety of supplemental REACT injections in participants with chronic kidney disease (CKD) who have previously received REACT treatment.
Read more